Supplementary Table 4. Pathway Analysis Based on Targeted Genes of Differential Mirna in ESCC

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary Table 4. Pathway Analysis Based on Targeted Genes of Differential Mirna in ESCC

Supplementary Table 4. Pathway analysis based on targeted genes of differential miRNA in ESCC

Pathway Count p-Value q-Value Gene

Signifi cant pathways targeted by downregulated miRNAs Focal adhesion 24 1.45E-18 2.58E-16 MET;MYLK;CRK;COL5A3;CDC42;ITGB1;PDGFC;PDGFRB;COL3A1; COL4A2;COL6A3;COL5A2;PTEN;FYN;CAV2;COL4A1;COL2A1; COL11A1;COL4A4;LAMC1;CCND2;COL1A1;AKT3;COL1A2 ECM-receptor 15 6.90E-15 4.78E-13 SV2A;CD47;COL5A3;ITGB1;COL3A1;COL4A2;COL6A3;COL5A2;COL4A1; interaction COL2A1;COL11A1;COL4A4;LAMC1;COL1A1;COL1A2 Axon guidance 17 2.39E-14 1.24E-12 MET;NRP1;EPHA7;GNAI3;KRAS;SEMA6A;RASA1;PPP3CA;SEMA3A;SRGAP1; CDC42;ITGB1;CFL2;FYN;PLXNA1;EPHB3;EPHA3 MAPK signaling 19 7.13E-11 1.06E-09 JUND;CRK;MAP3K3;DUSP1;KRAS;FGF1;RASA1;PPP3CA;DUSP6;RASA2; pathway FGF7;CDC42;FGF2;FGF13;PDGFRB;FOS;TNFRSF1A;GNG12;AKT3 Wnt signaling pathway 14 5.53E-10 6.77E-09 FZD8;PPP2R5D;FBXW11;CTBP2;TCF7;PPP2CA;PPP2CB;PPP3CA;FZD7; AXIN2;WNT3A;CAMK2G;CCND2;PRICKLE2 Regulation of actin 16 9.46E-10 1.09E-08 MYLK;CRK;PFN2;KRAS;FGF1;SSH2;ARPC5;FGF7;CDC42;FGF2;FGF13; cytoskeleton ITGB1;PDGFC;CFL2;PDGFRB;GNG12 Melanoma 10 2.58E-09 2.38E-08 MET;KRAS;FGF1;FGF7;FGF2;FGF13;PDGFC;PDGFRB;PTEN;AKT3 Small cell lung 10 1.73E-08 1.20E-07 RARB;BCL2L1;ITGB1;COL4A2;PTEN;TRAF4;COL4A1;COL4A4;LAMC1;AKT3 cancer Insulin signaling 12 1.82E-08 1.22E-07 CALM2;FRAP1;CRK;KRAS;IRS1;FOXO1;PRKAB2;CALM3;PPARGC1A;EIF4E2;AKT3;PPP pathway 1R3D Melanogenesis 10 1.09E-07 5.02E-07 CALM2;FZD8;ADCY6;TCF7;GNAI3;KRAS;FZD7;WNT3A;CAMK2G;CALM3 Tight junction 11 1.50E-07 6.79E-07 MAGI2;YES1;PPP2CA;PPP2CB;GNAI3;KRAS;PRKCE;CDC42;PTEN;CSDA;AKT3 Colorectal cancer 9 1.85E-07 8.19E-07 MET;FZD8;TCF7;KRAS;FZD7;AXIN2;PDGFRB;FOS;AKT3 Prostate cancer 9 2.77E-07 1.15E-06 HSP90B1;FRAP1;TCF7;KRAS;FOXO1;PDGFC;PDGFRB;PTEN;AKT3 Glioma 8 3.03E-07 1.23E-06 CALM2;FRAP1;KRAS;PDGFRB;PTEN;CAMK2G;CALM3;AKT3 Gap junction 9 4.47E-07 1.69E-06 GJA1;ADCY6;GNAI3;KRAS;HTR2C;PDGFC;PDGFRB;TUBB2A;TUBB2B Calcium signaling 11 3.03E-06 9.27E-06 MYLK;CALM2;HTR2C;PTGFR;PPP3CA;PDGFRB;CAMK2G;CALM3;HTR7;ATP2B1;OXTR pathway Renal cell carcinoma 7 7.63E-06 1.96E-05 MET;CRK;KRAS;EGLN1;CDC42;ARNT;AKT3 GnRH signaling 8 1.35E-05 3.16E-05 CALM2;MAP3K3;ADCY6;KRAS;CDC42;CAMK2G;CALM3;HBEGF pathway Pathogenic 6 1.92E-05 4.23E-05 ARPC5;CDC42;ITGB1;TUBB2A;FYN;TUBB2B Escherichia coli infection - EHEC Pathogenic 6 1.92E-05 4.23E-05 ARPC5;CDC42;ITGB1;TUBB2A;FYN;TUBB2B Escherichia coli infection - EPEC Adipocytokine 6 5.97E-05 1.03E-04 FRAP1;IRS1;TNFRSF1A;PRKAB2;PPARGC1A;AKT3 signaling pathway Methionine metabolism 4 7.70E-05 1.26E-04 DNMT3A;MAT2A;DNMT3B;MAT1A T cell receptor 7 1.23E-04 1.90E-04 KRAS;PPP3CA;CDC42;FOS;FYN;IFNG;AKT3 signaling pathway Selenoamino acid 4 1.27E-04 1.92E-04 SEPHS2;GGT7;MAT2A;MAT1A metabolism Adherens junction 6 1.50E-04 2.23E-04 MET;YES1;TCF7;CDC42;PVRL3;FYN Endometrial cancer 5 1.78E-04 2.53E-04 TCF7;KRAS;AXIN2;PTEN;AKT3 Jak-STAT signaling 8 1.88E-04 2.62E-04 SPRED1;BCL2L1;IL6ST;GHR;SPRY1;CCND2;IFNG;AKT3 pathway Basal cell carcinoma 5 2.32E-04 3.14E-04 FZD8;TCF7;FZD7;AXIN2;WNT3A ErbB signaling 6 2.55E-04 3.43E-04 FRAP1;CRK;KRAS;CAMK2G;HBEGF;AKT3 pathway SNARE interactions in 4 5.70E-04 6.66E-04 SNAP25;VAMP2;STX5;STX1A vesicular transport p53 signaling pathway 5 6.69E-04 7.60E-04 SHISA5;SESN1;PTEN;CCND2;PPM1D Long-term 5 9.78E-04 0.001057 CALM2;KRAS;PPP3CA;CAMK2G;CALM3 potentiation Chronic myeloid 5 9.78E-04 0.001057 CRK;CTBP2;BCL2L1;KRAS;AKT3 leukemia Phosphatidylinositol 5 0.001038 0.001077 CALM2;DGKH;DGKD;PTEN;CALM3 signaling system Notch signaling 4 0.001283 0.001286 CTBP2;RBPJ;MAML1;NCOR2 pathway Glycerolipid 4 0.001283 0.001286 DGKH;LPL;DGKD;GPAM metabolism Cytokine-cytokine 9 0.001465 0.001437 MET;IL6ST;INHBB;GHR;PDGFC;PDGFRB;TNFRSF1A;IFNG;CX3CL1 receptor interaction TGF-beta signaling 5 0.001898 0.001762 GDF6;PPP2CA;PPP2CB;INHBB;IFNG pathway Alzheimer's disease 7 0.002213 0.002019 CALM2;COX6A1;PPP3CA;LPL;TNFRSF1A;ATP5G1;CALM3 Acute myeloid 4 0.002978 0.002625 FRAP1;TCF7;KRAS;AKT3 leukemia Aminosugars 3 0.003047 0.002663 GNPDA2;GFPT2;NANP metabolism Glycerophospholipid 4 0.005229 0.004164 PISD;DGKH;DGKD;GPAM metabolism Long-term depression 4 0.005786 0.004576 PPP2CA;PPP2CB;GNAI3;KRAS Pancreatic cancer 4 0.006381 0.005008 BCL2L1;KRAS;CDC42;AKT3 B cell receptor 4 0.007015 0.005485 KRAS;PPP3CA;FOS;AKT3 signaling pathway VEGF signaling 4 0.007347 0.005723 KRAS;PPP3CA;CDC42;AKT3 pathway Fc epsilon RI 4 0.008404 0.006334 KRAS;PRKCE;FYN;AKT3 signaling pathway Type II diabetes 3 0.01051 0.007684 FRAP1;PRKCE;IRS1 mellitus Apoptosis 4 0.012633 0.008907 BCL2L1;PPP3CA;TNFRSF1A;AKT3 Ubiquitin mediated 5 0.013544 0.009518 UBE2Q1;FBXW11;UBA2;UBA6;UBE2J1 proteolysis mTOR signaling 3 0.015548 0.010673 FRAP1;EIF4E2;AKT3 pathway Neuroactive ligand- 7 0.01561 0.010681 PTH1R;HTR2C;PTGFR;GHR;CNR1;HTR7;OXTR receptor interaction Non-small cell lung 3 0.017196 0.011538 RARB;KRAS;AKT3 cancer Amyotrophic lateral 3 0.018937 0.012505 ALDH5A1;GFPT2 sclerosis (ALS) Glutamate metabolism 2 0.024102 0.015215 BCL2L1;PPP3CA;TNFRSF1A Biosynthesis of 2 0.032153 0.01967 HMGCR;SQLE steroids Heparan sulfate 2 0.032153 0.01967 HS3ST3B1;HS3ST2 biosynthesis Epithelial cell 3 0.033765 0.020475 MET;CDC42;HBEGF signaling in Helicobacter pylori infection Thyroid cancer 2 0.034309 0.020715 TCF7;KRAS Folate biosynthesis 2 0.043466 0.025289 GCH1;ENTPD7 Regulation of 2 0.048346 0.027595 GABARAPL1;IFNG autophagy Parkinson's disease 4 0.049101 0.027595 COX6A1;UBE2J1;ATP5G1;GPR37 Natural killer cell 4 0.051299 0.028416 KRAS;PPP3CA;FYN;IFNG mediated cytotoxicity Basal transcription 2 0.053415 0.029431 TBPL1;TAF5 factors Butanoate metabolism 2 0.056017 0.030743 ALDH5A1;HMGCS1 Sphingolipid 2 0.058663 0.032023 SGPP1;SMPD3 metabolism ABC transporters - 2 0.072504 0.038373 ABCA1;ABCB6 General Proteasome 2 0.084249 0.042898 PSME4;IFNG Glutathione 2 0.090324 0.04538 GGT7;GPX7 metabolism Lysine degradation 2 0.093408 0.046816 SUV420H1;SUV420H2 Hedgehog signaling 2 0.112515 0.053371 FBXW11;WNT3A pathway Arachidonic acid 2 0.112515 0.053371 GGT7;GPX7 metabolism Leukocyte 3 0.123286 0.056733 GNAI3;CDC42;ITGB1 transendothelial migration PPAR signaling 2 0.15676 0.069081 ANGPTL4;LPL pathway Toll-like receptor 2 0.274059 0.109413 FOS;AKT3 signaling pathway Cell cycle 2 0.336967 0.130036 MCM2;CCND2 Cell adhesion 2 0.391086 0.148713 ITGB1;PVRL3 molecules (CAMs) Oxidative 2 0.408696 0.154472 COX6A1;ATP5G1 phosphorylation Systemic lupus 2 0.426054 0.159963 H3F3B;IFNG erythematosus Purine metabolism 2 0.453259 0.168655 ADCY6;IMPDH1 Olfactory 3 0.747233 0.2689 CALM2;CAMK2G;CALM3 transduction Significant pathways targeted by upregulated miRNAs Calcium signaling 6 1.06E-05 1.02E-04 ATP2B1;PLCB1;VDAC1;ATP2B2;ATP2B4;ADCY9 pathway Ubiquitin mediated 5 3.73E-05 2.47E-04 WWP1;UBE2A;SKP1;ITCH;UBE2G1 proteolysis Non-small cell lung 3 4.14E-04 0.001391 FOXO3;RAF1;RB1 cancer Inositol phosphate 3 4.37E-04 0.001404 INPP5B;PLCB1;PIK3C2A metabolism Acute myeloid 3 5.37E-04 0.001508 RPS6KB1;RAF1;PIM1 leukemia Phosphatidylinositol 3 0.001125 0.002358 INPP5B;PLCB1;PIK3C2A signaling system TGF-beta signaling 3 0.00166 0.00285 RPS6KB1;ACVR2A;SKP1 pathway Prostate cancer 3 0.001715 0.00285 HSP90B1;RAF1;RB1 Gap junction 3 0.002009 0.003093 PLCB1;RAF1;ADCY9 Melanogenesis 3 0.00276 0.003781 PLCB1;RAF1;ADCY9 GnRH signaling 3 0.00299 0.004013 PLCB1;RAF1;ADCY9 pathway Cell cycle 3 0.004031 0.004722 CDC25A;SKP1;RB1 Axon guidance 3 0.005157 0.005665 RASA1;SEMA4C;EPHA3 Bladder cancer 2 0.00565 0.006111 RAF1;RB1 Parkinson's disease 3 0.005843 0.006256 SNCA;VDAC1;UBE2G1 Insulin signaling 3 0.006083 0.006448 RPS6KB1;RAF1;IRS2 pathway Jak-STAT signaling 3 0.008363 0.008363 SPRY2;SPRED1;PIM1 pathway mTOR signaling 2 0.008552 0.008433 RPS6KB1;DDIT4 pathway Endometrial cancer 2 0.008552 0.008433 FOXO3;RAF1 Glioma 2 0.013117 0.011605 RAF1;RB1 Renal cell carcinoma 2 0.01551 0.012844 EPAS1;RAF1 Long-term depression 2 0.01551 0.012844 PLCB1;RAF1 Melanoma 2 0.01551 0.012844 RAF1;RB1 Pancreatic cancer 2 0.016346 0.013227 RAF1;RB1 Long-term 2 0.017201 0.013761 PLCB1;RAF1 potentiation Chronic myeloid 2 0.017201 0.013761 RAF1;RB1 leukemia Focal adhesion 3 0.01767 0.013977 RAF1;COL2A1;COL1A2 ECM-receptor 2 0.021277 0.015662 COL2A1;COL1A2 interaction ErbB signaling 2 0.022716 0.016492 RPS6KB1;RAF1 pathway Cell adhesion 2 0.049932 0.025818 MPZ;NLGN2 molecules (CAMs) Maturity onset 1 0.062017 0.029189 HHEX diabetes of the young Wnt signaling pathway 2 0.06237 0.029189 PLCB1;SKP1 Purine metabolism 2 0.06237 0.029189 POLE4;ADCY9 Heparan sulfate 1 0.071975 0.032397 HS3ST1 biosynthesis O-Glycan biosynthesis 1 0.079375 0.034696 OGT Alzheimer's disease 2 0.081154 0.035111 PLCB1;SNCA DNA polymerase 1 0.091579 0.038445 POLE4 Base excision repair 1 0.091579 0.038445 POLE4 Nucleotide excision 1 0.110772 0.044646 POLE4 repair Type II diabetes 1 0.113142 0.045172 IRS2 mellitus Regulation of actin 2 0.115052 0.045676 RAF1;PFN2 cytoskeleton Notch signaling 1 0.117865 0.046618 JAG1 pathway Proteasome 1 0.120217 0.047372 PSME3 Lysine degradation 1 0.127235 0.049676 SETD8 Basal cell carcinoma 1 0.136507 0.052809 GLI3 Hedgehog signaling 1 0.141106 0.05439 GLI3 pathway Cholera - Infection 1 0.145681 0.055748 ADCY9 Cytokine-cytokine 2 0.154599 0.058737 CCL1;ACVR2A receptor interaction Adipocytokine 1 0.16374 0.061617 IRS2 signaling pathway MAPK signaling 2 0.166741 0.062454 RASA1;RAF1 pathway p53 signaling pathway 1 0.168195 0.062777 CCNG2 B cell receptor 1 0.18142 0.067475 RAF1 signaling pathway VEGF signaling 1 0.183604 0.068049 RAF1 pathway Fc epsilon RI 1 0.19012 0.070219 RAF1 signaling pathway Colorectal cancer 1 0.200867 0.07342 RAF1 Small cell lung 1 0.205126 0.07472 RB1 cancer Antigen processing 1 0.211473 0.076505 PSME3 and presentation Pyrimidine metabolism 1 0.219856 0.079268 POLE4 T cell receptor 1 0.252516 0.086205 RAF1 signaling pathway Natural killer cell 1 0.308293 0.096115 RAF1 mediated cytotoxicity

Recommended publications